USPTO serial 79312865
BACHEM LEADING PARTNER IN TIDES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BERTRAND, JOSEPH A
- Law office
- TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BACHEM LEADING PARTNER IN TIDES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals intended for industry and science; chemical preparations for scientific use; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific use; reagents for chemical analyses; chemical preparations for scientific use, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; industrial chemicals; chemical reagents for scientific use; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; small molecules for use in industry and science; oligopeptides for industrial use; proteins for industrial use; oligonucleotides for industrial use; proteins for use in manufacture; oligonucleotides for use in manufacture; amino acids for industrial purposes; amino acids for scientific use; peptide substrates for scientific use; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; small molecules for use in manufacture of cosmetics; chemical preparations for use in the manufacture of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; small molecules for use in manufacture of pharmaceutical products; chemical reagents for genetic research; chemical products for use in biotechnological manufacturing processes; chemical products used in the development of biotechnological products; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of anti-cancer medicines; active chemical ingredients for use in the manufacture of medicines against diabetes; active chemical ingredients for use in the manufacture of medicines against metabolic diseases; active chemical ingredients for use in the manufacture of medicines for wound healing; active chemical ingredients for use in the manufacture of medicines against genetic diseases; active chemical ingredients for use in the manufacture of medicines against neurological diseases; amides for use in manufacture; chemical additives for use in manufacture; chemical additives for use in manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research use; diagnostic preparations, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical or veterinary use; biological preparations for use in industry and science; biological preparations, other than for medical or veterinary use; additives, other than for medical or veterinary use; biochemical catalysts; biochemical precursors for scientific use; biochemical preparations for scientific use; oligonucleotides for scientific use; proteins for scientific use; peptides for scientific use; biochemical products for in-vitro and in-vivo scientific use; emollients for industrial use; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceutical products; enzyme stabilizers; enzymatic substrates; phosphoproteins | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary use; reagents for medical use; chemical preparations for medical use; peptides for medical use; proteins for medical use; oligonucleotides for medical use; small molecules for medical use; amino acids for medical use; chemical preparations for pharmaceutical use; peptides for pharmaceutical use; synthetic peptides for pharmaceutical use; proteins for pharmaceutical use; oligonucleotides for pharmaceutical use; small molecules for pharmaceutical use; chemical preparations for veterinary use; peptides for veterinary use; proteins for veterinary use; oligonucleotides for veterinary use; small molecules for veterinary use; amino acids for veterinary use; pharmaceutical preparations; pharmaceutical preparations containing amino acids; pharmaceutical substances; chemical-pharmaceutical preparations; diagnostic preparations for medical purposes; diagnostic preparations for veterinary use; biological and pharmaceutical preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary use; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; small molecules for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; chemical preparations for the diagnosis of pregnancy; biochemical preparations for medical or veterinary use; biological and chemical reagents for medical or veterinary use; biological preparations for diagnostic purposes; biological preparations for medical use; biological preparations for veterinary use; preparations against metabolic diseases; preparations for wound healing; preparations against genetic diseases; preparations against neurological diseases; biological reagents for medical use; biological reagents for veterinary use; adjuvants for medical use; adjuvants for veterinary use; antibacterial preparations; anti-cancer preparations; anti-tumor medicines; biopharmaceutical products for cancer treatment; biotechnological preparations for medical use; anti-cancer preparations; anti-diabetic preparations; pharmaceutical preparations for use in chemotherapy; clinical diagnostic reagents; cosmeceuticals for therapeutic or medical use; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic substances adapted for medical use; dietetic substances adapted for veterinary use; drug delivery agents; injectable solutions for medical use; in-vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing | ACTIVE | — |
| 040 | Custom manufacturing; custom manufacture of pharmaceutical products; custom manufacture of biopharmaceutical products; custom manufacture of peptides; custom manufacture of proteins; custom manufacture of oligonucleotides; custom manufacture of small molecules; treatment of materials; treatment of chemical products; treatment of chemical reagents; treatment of peptides; treatment of proteins; treatment of oligonucleotides; treatment of small molecules; treatment of medicinal materials; treatment of biopharmaceutical materials for third parties; refining services; treatment of materials; treatment of biopharmaceutical materials; treatment of materials on request for third parties; treatment of materials for third parties | ACTIVE | — |
| 042 | Scientific research; chemical research; chemistry services; chemical engineer; research and development of products; research and development of new products for third parties; industrial research, development and testing; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development in the field of small molecules; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of manufacturing processes; development of analytical methods; scientific laboratory services; chemical and biological laboratory services; scientific and industrial analysis and research services; laboratory research and analysis; chemical analysis; industrial analysis; laboratory analysis services; chemical, biochemical, biological and bacteriological research and analysis; analysis in the field of molecular biology; computer-assisted scientific research, testing and analysis services; conducting of scientific studies; preparation of reports concerning scientific research; provision of information on industrial analysis and research services; quality control; product testing; evaluation of chemical analyses; evaluation of chemical syntheses; evaluation of product development; consulting services relating to testing of materials; consultation in the field of biochemistry; consultation in the field of chemistry; consulting in the field of scientific and industrial research; consultation relating to laboratory testing; consulting services in the field of recombinant DNA technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 4, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 16, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 7, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 7, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 7, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 26, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 11, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 10, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |